These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. What is the most effective strategy for managing diabetic dyslipidaemia? Reasner CA. Atheroscler Suppl; 2005 Sep; 6(3):21-7. PubMed ID: 16054442 [Abstract] [Full Text] [Related]
9. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C. Chapman MJ, Assmann G, Fruchart JC, Shepherd J, Sirtori C, European Consensus Panel on HDL-C. Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528 [Abstract] [Full Text] [Related]
11. High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies. Toth PP. Am J Cardiol; 2005 Nov 07; 96(9A):50K-58K; discussion 34K-35K. PubMed ID: 16291015 [Abstract] [Full Text] [Related]
19. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease. Staels B, Maes M, Zambon A. Nat Clin Pract Cardiovasc Med; 2008 Sep 07; 5(9):542-53. PubMed ID: 18628776 [Abstract] [Full Text] [Related]
20. [HDL and CETP in atherogenesis]. Pöss J, Böhm M, Laufs U. Dtsch Med Wochenschr; 2010 Feb 07; 135(5):188-92. PubMed ID: 20082258 [Abstract] [Full Text] [Related] Page: [Next] [New Search]